People using drugs like Ozempic are discovering an unwanted side affect: facial aging.
Category: Drugs (Pharmaceuticals)
-
The Only H.I.V. Vaccine in Advanced Trials Has Failed. What Now?
Janssen Pharmaceuticals ended a global trial after independent experts determined the vaccine was not effective. But there are other possibilities in the pipeline, scientists said.
-
California Sues Companies Over Insulin Prices, Joining Other States
The state is taking action against three major drug companies and the big pharmacy benefit managers in an effort to temper costs for people with diabetes.
-
The Father of the Abortion Pill
The 96-year-old scientist who came up with an idea for an “unpregnancy pill” decades ago has led an eventful life, from his teenage days in the French Resistance to his friendships with famous artists.
-
Medicare Begins to Rein In Drug Costs for Older Americans
Reforms embedded in the Inflation Reduction Act will bring savings to seniors this year. Already some lawmakers are aiming to repeal the changes.
-
F.D.A. Approves New Treatment for Early Alzheimer’s
The drug, Leqembi, may modestly slow cognitive decline in early stages of the disease but carries some safety risks. Still, data suggests it is more promising than the small number of other available treatments.
-
Abortion Pills Can Now Be Offered at Retail Pharmacies, F.D.A. Says
Mifepristone, the first of two drugs in medication abortions, previously had to be dispensed only by clinics, doctors or a few mail-order pharmacies. Now, if local drugstores or chains like CVS agree to certain rules, they can provide it.
-
Justice Dept. Sues AmerisourceBergen Over Role in Opioid Crisis
Investigators said the pharmaceutical manufacturer, one of the nation’s largest, had knowingly distributed opioids that were later resold illegally.
-
Congressional Investigation into Alzheimer’s Drug Aduhelm Faults the F.D.A. and Biogen
The report said the F.D.A.’s approval process for Aduhelm was “rife with irregularities” and criticized Biogen for setting an “unjustifiably high price.”
-
China’s Abrupt Covid Pivot Leaves Many Without Medicines
Millions are desperate to get their hands on fever-reducing drugs and antivirals such as Pfizer’s Paxlovid as infections across China outpace supplies.
-
Can a Federally Funded ‘Netflix Model’ Fix the Broken Market for Antibiotics?
Shortages and drug-resistant germs have renewed attention on a $6 billion proposal in Congress that would reconfigure the way antimicrobial drugs are developed and sold.
-
Alzheimer’s Drug May Benefit Some Patients, New Data Shows
The drug, lecanemab, made by Eisai and Biogen, also carried risks of brain swelling and bleeding and should be studied further, a report of the findings said.